Cumulative Secondary Dysautonomia, Recovery Trajectories, and Clinical Recovery Flags An Integrated Framework for Longitudinal Autonomic Assessment Linking BRR Theory, MSAD, ALAS/ALI, the Recovery-Weighted Model, RWCAM, and Clinical Recovery Flags

Background: Autonomic assessment is often organised around the clinical snapshot: the symptom score, haemodynamic result, laboratory severity grade, or diagnosis visible at one encounter. These measurements are essential, but they may not reconstruct the cumulative pathway by which multifactorial secondary dysautonomia developed, show how resilience and reserve shaped its expression, distinguish restoration from compensation, or represent asynchronous recovery across organ systems. Problem: Existing tools measure autonomic symptoms, laboratory-confirmed failure, or defined haemodynamic syndromes. No single established approach represented in the literature considered here combines the chronology of multiple secondary contributors, changing adaptive capacity, eight-domain autonomic burden, evidentiary confidence, recovery direction, recovery velocity, domain-specific stages, and candidate early signals of network repair. Original Contribution: This paper consolidates a linked programme of original secondary-dysautonomia scholarship. BRR Theory explains how cumulative burden may exceed resilience and remaining autonomic reserve. The proposed Multifactorial Secondary Autonomic Dysfunction (MSAD) phenotype gives that cumulative pattern a bounded clinical formulation. ALAS/ALI converts present burden into an eight-domain profile while separating severity from confidence. The Recovery-Weighted Model interprets the biological and functional meaning of change; RWCAM supplies a repeatable longitudinal language; and five candidate clinical recovery flags make early network-level improvement observable and prospectively testable. The conceptual system is operationalised in a six-part, research-use-only Clinical Working Cameo Suite that provides linked worksheets for chronology, phenotype formulation, burden profiling, recovery-weighted interpretation, longitudinal staging, and prospective recovery-flag observation. Implications: The integrated framework makes several clinically consequential distinctions explicit: cumulative coherence is not proof of causation; burden is not certainty; symptom reduction is not necessarily physiological recovery; compensation is not restoration; apparently stable function may depend on increasing support; and different autonomic domains may recover, plateau, or deteriorate at different rates. It offers a structured research and clinical-reasoning agenda rather than a diagnostic, prognostic, or treatment instrument. Conclusion: The originality of the work lies not in claiming that burden, resilience, reserve, function, or longitudinal assessment are individually unknown. It lies in arranging these concepts around a neglected clinical object: cumulative, multisystem secondary dysautonomia whose development and recovery cannot be represented adequately by one diagnosis, one organ, one score, or one encounter. Independent expert review, co-design, psychometric development, prospective multisystem testing, and external validation are now required. The six companion cameos make that architecture auditable and prospectively testable without converting it into a diagnostic, prognostic, or treatment system.